Characterization of Two Seryl-tRNA Synthetases in Albomycin-Producing Streptomyces sp. Strain ATCC 700974

Antimicrobial Agents and Chemotherapy
2009.0

Abstract

<jats:title>ABSTRACT</jats:title> <jats:p> The Trojan horse antibiotic albomycin, produced by <jats:italic>Streptomyces</jats:italic> sp. strain ATCC 700974, contains a thioribosyl nucleoside moiety linked to a hydroxamate siderophore through a serine residue. The seryl nucleoside structure (SB-217452) is a potent inhibitor of seryl-tRNA synthetase (SerRS) in the pathogenic bacterium <jats:italic>Staphylococcus aureus</jats:italic> , with a 50% inhibitory concentration (IC <jats:sub>50</jats:sub> ) of ∼8 nM. In the albomycin-producing <jats:italic>Streptomyces</jats:italic> sp., a bacterial SerRS homolog (Alb10) was found to be encoded in a biosynthetic gene cluster in addition to another <jats:italic>s</jats:italic> <jats:italic>erRS</jats:italic> gene ( <jats:italic>serS1</jats:italic> ) at a different genetic locus. Alb10, named SerRS2 herein, is significantly divergent from SerRS1, which shows high homology to the housekeeping SerRS found in other <jats:italic>Streptomyces</jats:italic> species. We genetically and biochemically characterized the two genes and the proteins encoded. Both genes were able to complement a temperature-sensitive <jats:italic>serS</jats:italic> mutant of <jats:italic>Escherichia coli</jats:italic> and allowed growth at a nonpermissive temperature. <jats:italic>serS2</jats:italic> was shown to confer albomycin resistance, with specific amino acid residues in the motif 2 signature sequences of SerRS2 playing key roles. SerRS1 and SerRS2 are comparably efficient in vitro, but the <jats:italic> K <jats:sub>m</jats:sub> </jats:italic> of serine for SerRS2 measured during tRNA aminoacylation is more than 20-fold higher than that for SerRS1. SB-217452 was also enzymatically generated and purified by two-step chromatography. Its IC <jats:sub>50</jats:sub> against SerRS1 was estimated to be 10-fold lower than that against SerRS2. In contrast, both SerRSs displayed comparable inhibition kinetics for serine hydroxamate, indicating that SerRS2 was specifically resistant to SB-217452. These data suggest that mining <jats:italic>Streptomyces</jats:italic> genomes for duplicated aminoacyl-tRNA synthetase genes could provide a novel approach for the identification of natural products targeting aminoacyl-tRNA synthetases.

Knowledge Graph

Similar Paper

Characterization of Two Seryl-tRNA Synthetases in Albomycin-Producing <i>Streptomyces</i> sp. Strain ATCC 700974
Antimicrobial Agents and Chemotherapy 2009.0
A Potent Seryl tRNA Synthetase Inhibitor SB-217452 Isolated from a Streptomyces species.
The Journal of Antibiotics 2000.0
The Insect Pathogen Serratia marcescens Db10 Uses a Hybrid Non-Ribosomal Peptide Synthetase-Polyketide Synthase to Produce the Antibiotic Althiomycin
PLoS ONE 2012.0
Investigations of valanimycin biosynthesis: Elucidation of the role of seryl-tRNA
Proceedings of the National Academy of Sciences 2008.0
Indolmycin Resistance of Streptomyces coelicolor A3(2) by Induced Expression of One of Its Two Tryptophanyl-tRNA Synthetases
Journal of Biological Chemistry 2002.0
The complete genome sequence of Streptomyces albolongus YIM 101047, the producer of novel bafilomycins and odoriferous sesquiterpenoids
Journal of Biotechnology 2017.0
A Novel Enzyme Conferring Streptothricin Resistance Alters the Toxicity of Streptothricin D from Broad-spectrum to Bacteria-specific
Journal of Biological Chemistry 2006.0
SB-219383, a Novel Tyrosyl tRNA Synthetase Inhibitor from a Micromonospora sp. I. Fermentation, Isolation and Properties.
The Journal of Antibiotics 2000.0
A Branch Point of Streptomyces Sulfur Amino Acid Metabolism Controls the Production of Albomycin
Applied and Environmental Microbiology 2016.0
Isolation and characterization of the tobramycin biosynthetic gene cluster from<i>Streptomyces tenebrarius</i>
FEMS Microbiology Letters 2004.0